Commentary: Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With Brugada Syndrome
- PMID: 34177625
- PMCID: PMC8220137
- DOI: 10.3389/fphys.2021.682567
Commentary: Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With Brugada Syndrome
Keywords: Brugada syndrome; CACNA1C; L-type calcium channel; drug; mutations; personalized medicine; pharmaceutical.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
-
Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With Brugada Syndrome.Front Physiol. 2021 Jan 8;11:616819. doi: 10.3389/fphys.2020.616819. eCollection 2020. Front Physiol. 2021. PMID: 33488405 Free PMC article.
Similar articles
-
Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With Brugada Syndrome.Front Physiol. 2021 Jan 8;11:616819. doi: 10.3389/fphys.2020.616819. eCollection 2020. Front Physiol. 2021. PMID: 33488405 Free PMC article.
-
Nonsense-mediated mRNA decay due to a CACNA1C splicing mutation in a patient with Brugada syndrome.Heart Rhythm. 2014 Apr;11(4):629-34. doi: 10.1016/j.hrthm.2013.12.011. Epub 2013 Dec 7. Heart Rhythm. 2014. PMID: 24321233
-
Novel long QT syndrome-associated missense mutation, L762F, in CACNA1C-encoded L-type calcium channel imparts a slower inactivation tau and increased sustained and window current.Int J Cardiol. 2016 Oct 1;220:290-8. doi: 10.1016/j.ijcard.2016.06.081. Epub 2016 Jun 23. Int J Cardiol. 2016. PMID: 27390944 Free PMC article.
-
Mechanisms of disease: current understanding and future challenges in Brugada syndrome.Nat Clin Pract Cardiovasc Med. 2005 Aug;2(8):408-14. doi: 10.1038/ncpcardio0268. Nat Clin Pract Cardiovasc Med. 2005. PMID: 16119703 Review.
-
Calcium Channel Mutations in Cardiac Arrhythmia Syndromes.Curr Mol Pharmacol. 2015;8(2):133-42. doi: 10.2174/1874467208666150518114857. Curr Mol Pharmacol. 2015. PMID: 25981977 Free PMC article. Review.
Cited by
-
The Mechanism of Ajmaline and Thus Brugada Syndrome: Not Only the Sodium Channel!Front Cardiovasc Med. 2021 Dec 23;8:782596. doi: 10.3389/fcvm.2021.782596. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 35004896 Free PMC article. Review.
-
Brugada Syndrome: Warning of a Systemic Condition?Front Cardiovasc Med. 2021 Oct 15;8:771349. doi: 10.3389/fcvm.2021.771349. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34722688 Free PMC article. Review.
References
-
- Antzelevitch C., Pollevick G. D., Cordeiro J. M., Casis O., Sanguinetti M. C., Aizawa Y., et al. . (2007). Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 115, 442–449. 10.1161/CIRCULATIONAHA.106.668392 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
